US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist
  • 37.980
  • -0.110-0.29%
Close Apr 28 16:00 ET
  • 37.410
  • -0.570-1.50%
Post 16:33 ET
3.57BMarket Cap-6.04P/E (TTM)

About Ultragenyx Pharmaceutical Company

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Company Profile

SymbolRARE
Company NameUltragenyx Pharmaceutical
Listing DateJan 31, 2014
Issue Price21.00
Founded2010
CEODr. Emil D. Kakkis, M.D.,PhD
MarketNASDAQ
Employees1294
Fiscal Year Ends12-31
Address60 Leveroni Court
CityNovato
ProvinceCalifornia
CountryUnited States of America
Zip Code94949
Phone1-415-483-8800
Websitehttp://www.ultragenyx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Emil D. Kakkis, M.D.,PhD
  • Director, President and Chief Executive Officer
  • 4.34M
  • Theodore A. Huizenga
  • Senior Vice President, Corporate Controller and Chief Accounting Officer
  • --
  • Karah Parschauer
  • Chief Legal Officer and Executive Vice President, Corporate Affairs
  • --
  • Thomas R. Kassberg
  • Chief Business Officer and Executive Vice President
  • --
  • John Richard Pinion, II
  • Chief Quality Officer and Executive Vice President, Translational Sciences
  • 2.05M
  • Howard Horn
  • Chief Financial Officer and Executive Vice President, Corporate Strategy
  • 2.02M
  • Erik Harris
  • Chief Commercial Officer and Executive Vice President
  • 2.02M
  • Dennis Karl Huang
  • Chief Technical Operations Officer and Executive Vice President, Gene Therapy Operations
  • --
  • Dr. Eric Crombez, M.D.
  • Executive Vice President and Chief Medical Officer
  • 2.03M
  • Daniel G. Welch
  • Chairman of the Board
  • 500.13K
  • Michael A. Narachi
  • Independent Director
  • 481.88K
  • Matthew K. Fust
  • Independent Director
  • 480.13K
  • Dr. Shehnaaz Suliman, M.D.
  • Independent Director
  • 468.26K
  • Dr. Deborah L. Dunsire,M.D.
  • Independent Director
  • 466.76K
  • Dr. Corazon Dating Sanders, PhD
  • Independent Director
  • 469.26K
  • Dr. Amrit Ray, M.D.
  • Independent Director
  • 464.13K

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Guangdong Hongjing Optoelectronic Technology Inc.
301479
+20.00%
Longkou Union Chemical
301209
+20.00%
Zhejiang Realsun Chemical
301212
+19.98%
4
NEW JCM GROUP
300157
+19.92%
5
Shenzhen S-king Intelligent Equipment
688328
+15.32%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀